Transfusion of Blood Products: Commonly Asked Questions
Transfusion of Blood Products: Commonly Asked Questions
Transfusion of Blood Products: Commonly Asked Questions
Transfusion of
Blood Products
Commonly Asked Questions
Alberta Wide
Transfusion Medicine Group
May 2003
The following common questions and answers have been prepared to help you understand what transfusion treatment
you may receive and why it may help you.
What is a transfusion?
A transfusion is the injection of a blood product through a needle inserted into a patient’s vein. Many blood
products are made by Canadian Blood Services (CBS) from human blood donated by volunteers across Canada.
Commonly transfused blood products are red cells, platelets and plasma.
Blood and blood products are given to patients who have specific medical needs. Patients are encouraged to ask
their doctor questions about transfusion. Blood and its products are chosen to replace what has been lost because of
disease or injury. It is important to remember that receiving blood products when they are needed can save a life.
• Red Blood Cells: Red blood cells carry oxygen from the lungs to the body’s vital organs such as the heart. A
red cell transfusion may be necessary to prevent organ damage caused by a lack of oxygen. Currently there
is no proven substitute for blood if it is needed quickly.
• Platelets: Platelets are blood cells essential for the body to form a blood clot and prevent or stop bleeding at the
site of injury. A platelet transfusion may be needed if the platelet count is at a low level or if the platelets are not
working properly.
• Plasma: Plasma is the clear liquid part of the blood. There are many dissolved substances in the plasma. Clotting
proteins are among the most important of these. A plasma transfusion may be needed to prevent bleeding or to
help stop bleeding which has started because levels of clotting factors are too low.
• Blood products made from plasma: Plasma may be further separated into a number of blood products that can
be used to help blood clot, prevent infection or preserve blood volume.
• Blood products made from plasma: Plasma may be further separated into a number of blood products that can
be used to help blood clot, prevent infection or preserve blood volume.
What are the risks of transfusion?
Risks of transfusion range from common minor reactions, to very rare but life-threatening reactions or problems
caused by transmission of infection or transfusion of incorrect units of blood. Some of the reactions and problems
are:
• Allergic Reaction: This reaction is common and usually mild. Some patients experience itching or a rash.
The doctor easily treats most allergic reactions. Severe allergic reactions such as breathing problems are
rare.
• Fever Reaction: This reaction is uncommon and usually occurs during or shortly after the transfusion. The
symptoms may include fever, chills or flushing. Patients who have had a fever reaction with transfusion in the
past should tell their doctor so steps can be taken to prevent these reactions from happening again.
• Hemolytic Reaction: This serious and sometimes life threatening reaction occurs when the patient’s blood
destroys transfused blood cells, and can result in kidney failure. Fortunately such a reaction is rare. It is usually
caused by transfusion of an incorrect unit of blood product. The blood the patient receives is carefully tested
for blood type by the Transfusion Services Laboratory and identified by the health care worker at the bedside,
to ensure it is the correct blood product.
• Infection: Canada’s blood supply comes from volunteer donors and there are several processes by which
Canadian Blood Services ensures the greatest possible safety. In addition to a questionnaire, donors are screened
and individually interviewed by Canadian Blood Services nursing staff prior to each donation. Every
donation is tested for hepatitis, HIV (the AIDS virus), and other infectious agents, including, as of July 2003,
West Nile Virus. While this testing reduces the chance of catching an infection from a blood transfusion, this
risk cannot be completely eliminated. Patients are urged to discuss the risk of infection with their doctor.
As described earlier, red blood cells carry the oxygen in blood to vital organs such as the brain and heart. A
decrease in oxygen could result in damage to these organs. Platelets and plasma help the blood to clot. Without
these cells, excessive bleeding can result causing a dangerous loss of red blood cells. The point at which transfusion
becomes necessary varies from case to case.
In certain circumstances, medications can be used to help avoid the need for blood or blood products. The patient
should ask the doctor about this possibility. Iron pills and certain vitamin supplements such as Folic Acid or
Vitamin B12 injections may be helpful. A synthetic blood-forming hormone called Erythropoietin may also be
helpful in very special circumstances.
• Autologous Donation: Refers to the collection of a patient’s blood that may be used for later transfusion.
Blood collected before surgery can be stored for up to 35 days. The surgeon helps the patient make this
decision. Travel to a larger centre may be necessary for autologous donation.
• Directed Donation: Refers to the process where a specific donor’s blood is assigned to a specific patient.
Patients with rare blood types, bone marrow transplant patients and minor age children may qualify to receive
blood from this program. Directed donation is not routinely available. The doctor can arrange a directed donation
if this is appropriate.
Can I use my computer to go online and find more information about blood transfusions?
Information on blood transfusion, including benefits and risks is updated frequently. Current information related
to transfusion risks, including the risk of transfusion related West Nile Virus infection can be found on several
websites including:
Prepared by:
Perioperative Blood Conservation Program Calgary Health Region. The information in this brochure is based
on the Alberta Clinical Practice Guideline for Red Blood Cell and Plasma Transfusion: A Summary. October
2002